Okomera is pioneering automation and miniaturization of personalized tumor biopsy studies. This groundbreaking technology was invented and patented by our co-founders at Ecole polytechnique.
Employees: 11-50
Founded date: 2020
Investors 2
| Date | Name | Website |
| 05.04.2023 | Berkeley S... | skydeck.be... |
| - | Agoranov | agoranov.c... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 26.03.2024 | Neogap secures Eurostars funding to develop T-cell activity ... | Neogap secures Eurostars funding to develop T-cell activity analysis Tue, Mar 26, 2024 07:30 CET Rep... | news.cisio... |
| - | Okomera | “Okomera is developing an innovative approach to accelerate the development of personalized cancer t... | fastfounde... |